↓ Skip to main content

Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

Overview of attention for article published in Frontiers in Pharmacology, January 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy
1 policy source
twitter
3 X users
facebook
2 Facebook pages

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
114 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs
Published in
Frontiers in Pharmacology, January 2013
DOI 10.3389/fphar.2013.00039
Pubmed ID
Authors

Rickard E. Malmström, Brian B. Godman, Eduard Diogene, Christoph Baumgärtel, Marion Bennie, Iain Bishop, Anna Brzezinska, Anna Bucsics, Stephen Campbell, Alessandra Ferrario, Alexander E. Finlayson, Jurij Fürst, Kristina Garuoliene, Miguel Gomes, Iñaki Gutiérrez-Ibarluzea, Alan Haycox, Krystyna Hviding, Harald Herholz, Mikael Hoffmann, Saira Jan, Jan Jones, Roberta Joppi, Marija Kalaba, Christina Kvalheim, Ott Laius, Irene Langner, Julie Lonsdale, Sven-Äke Lööv, Kamila Malinowska, Laura McCullagh, Ken Paterson, Vanda Markovic-Pekovic, Andrew Martin, Jutta Piessnegger, Gisbert Selke, Catherine Sermet, Steven Simoens, Cankat Tulunay, Dominik Tomek, Luka Vončina, Vera Vlahovic-Palcevski, Janet Wale, Michael Wilcock, Magdalena Wladysiuk, Menno van Woerkom, Corrine Zara, Lars L. Gustafsson

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Indonesia 1 <1%
Austria 1 <1%
Brazil 1 <1%
Slovenia 1 <1%
Luxembourg 1 <1%
Unknown 109 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 25 22%
Student > Ph. D. Student 12 11%
Researcher 7 6%
Professor 7 6%
Student > Bachelor 7 6%
Other 29 25%
Unknown 27 24%
Readers by discipline Count As %
Medicine and Dentistry 44 39%
Pharmacology, Toxicology and Pharmaceutical Science 10 9%
Social Sciences 9 8%
Economics, Econometrics and Finance 6 5%
Agricultural and Biological Sciences 4 4%
Other 11 10%
Unknown 30 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2022.
All research outputs
#6,262,281
of 23,504,998 outputs
Outputs from Frontiers in Pharmacology
#2,529
of 17,072 outputs
Outputs of similar age
#65,576
of 284,620 outputs
Outputs of similar age from Frontiers in Pharmacology
#30
of 167 outputs
Altmetric has tracked 23,504,998 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 17,072 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 284,620 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 167 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.